Category: by country

Chemist fighting to keep PhD asks University of Texas to pay $95k in legal fees

University of Texas

After the University of Texas postponed a hearing to determine whether it should revoke a chemist’s PhD, her lawyer has filed a motion to stop the proceedings, and requested the school pay her $95,099 in lawyer fees and expenses.

This is the second time UT has threatened to revoke Suvi Orr‘s PhD, following a 2012 retraction for a paper that made up part of her dissertation, which the school alleged contained falsified data. UT revoked her degree in 2014, only to reinstate it after she sued. The school is now trying to revoke it again, but the scheduled hearing on March 4 was postponed. Last week, her lawyer filed a motion for final summary judgment requesting that UT stop the proceedings and repay $95,099 in lawyer fees and expenses. The new motion makes a few requests:

Continue reading Chemist fighting to keep PhD asks University of Texas to pay $95k in legal fees

Paper calls water “a gift from God”

renewableA paper about using solar energy to make water potable has been flagged for citing God.

The shout-out isn’t subtle; in fact, it’s the first sentence of the Introduction in “Solar still with condenser – A detailed review:”

Water is a gift from God and it plays a key role in the development of an economy and in turn for the welfare of a nation.

The paper itself contains a few similarities to a 2010 paper on the same topic, “Active solar distillation—A detailed review,” which also appeared in Renewable and Sustainable Energy Reviews. But that paper phrases the first sentence of the introduction slightly differently: Continue reading Paper calls water “a gift from God”

Poll: Should there be a way to “self-retract” for honest error?

Daniele Fanelli
Daniele Fanelli

This week in Nature, Daniele Fanelli at Stanford made an interesting proposal: Set up a system of “self-retraction” that makes it crystal clear when a paper is pulled for honest error, rather than misconduct.

Fanelli, a whose work we have frequently covered, rightly notes that honest error represents a minority of retractions — around 20%. To remove any hint that a paper contains misconduct, Fanelli proposes designating self-retractions as those where all authors sign the retraction note:

Continue reading Poll: Should there be a way to “self-retract” for honest error?

Biologist’s research under investigation in Sweden after being questioned on PubPeer

Holgersson
Suchitra Sumitran-Holgersson

The University of Gothenburg in Sweden is investigating several papers co-authored by biologist Suchitra Sumitran-Holgersson after they were challenged on PubPeer.

Sumitran-Holgersson already has one retraction under her belt — of a 2005 Blood paper, after another investigation concluded the results “cannot be considered reliable.” Sumitran-Holgersson and her husband, co-author Jan Holgersson, did not sign the retraction notice. Both were based at the Karolinska Institutet (KI) at the time, but have since moved to the University of Gothenburg.

Now, the University of Gothenburg has launched its own investigation of the papers questioned on PubPeer, according to Continue reading Biologist’s research under investigation in Sweden after being questioned on PubPeer

Macchiarini dismissed from Karolinska

Paolo Macchiarini
Paolo Macchiarini

The Karolinska Institutet has dismissed former rising star surgeon Paolo Macchiarini from his post, effective immediately.

A KI news release, dated today, states:

The Staff Disciplinary Board at Karolinska Institutet has today decided to relieve Paolo Macchiarini of his duties as a researcher at KI. He is to be informed immediately that his contract has been rescinded.

For a refresher on the story, check out our constantly updating timeline. As a brief recap: Continue reading Macchiarini dismissed from Karolinska

NEJM: No plan to clarify wording that led to allegations of breached confidentiality

NEJMThe New England Journal of Medicine (NEJM) has no plans to change the wording of an article that led to allegations of breached patient confidentiality and caused a minor social media firestorm this past weekend, the journal told Retraction Watch.

The paragraph in question appeared in an essay by Lisa Rosenbaum chronicling the history of power morcellation, a technique to remove gynecological organs that the FDA has subjected to a “black box warning” because it can also spread tumors: Continue reading NEJM: No plan to clarify wording that led to allegations of breached confidentiality

FDA bans trial coordinator who pocketed patient funds and went to prison

The U.S. Food and Drug Administration (FDA) has permanently debarred a clinical trial coordinator from working on drug applications after he swapped patient stool samples for his own, and pocketed the money earmarked for patients — along with forging patient records, lab work, and doctors’ signatures.

The debarment is moot for time being — last year, Wesley McQuerry was sentenced to three years in prison for his misdeeds, according to the Chicago Sun-Times.

The FDA’s debarment, effective March 18, provides more details: Continue reading FDA bans trial coordinator who pocketed patient funds and went to prison

Environmental journal pulls two papers for “compromised” peer review

EGAHEnvironmental Geochemistry and Health has retracted two papers after an investigation suggested that the peer-review process had been compromised.

In case you’re counting, we’ve now logged approximately 300 retractions stemming from likely faked or rigged peer review.

The retraction note — which is the same for both papers — explains a bit more about the situation: Continue reading Environmental journal pulls two papers for “compromised” peer review

Antifungal drug paper didn’t have institution’s approval

Authors have pulled a paper on an antifungal drug that is potentially toxic because it lacked final approval from their institution.

The study describes a patient who had experienced liver toxicity after taking voriconazole. During the study, the authors re-administered the drug to the patient using “a slow dose titration.” But their institution didn’t approve the study before it was published online.

Here’s the retraction note for “Successful Rechallenge with Voriconazole following Medication-Induced Hepatotoxicity,” published in Antimicrobial Agents and Chemotherapy.  Continue reading Antifungal drug paper didn’t have institution’s approval

Corrections chip away at asbestos paper for conflicts of interest, “misleading” citation

EBPHThe journal Epidemiology Biostatistics and Public Health has issued back-to-back corrections for a 2015 paper after the authors failed to disclose conflicts of interest with the asbestos industry and included an “erroneous citation.”

The mistaken citation was more than just a clerical error, critics argue — it undermines one of the key arguments of the paper, “Critical reappraisal of Balangero chrysotile and mesothelioma risk,” which disputes claims that an asbestos mine in northwest Italy was responsible for numerous cases of an aggressive form of cancer called mesothelioma. The authors, led by Edward Ilgren formerly of Oxford University, claim that “myriad sources” of other forms of asbestos—rather than the asbestos produced at the mine, called chrysotile—exist in the region “to account for the alleged cases.”

However, according to a recently added correction, the citation does not support one of the authors’ claims about how other forms of asbestos arrived at the mine area.

Continue reading Corrections chip away at asbestos paper for conflicts of interest, “misleading” citation